Tata India Pharma & Healthcare Fund vs Nippon India Pharma Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Chart Comparison
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹8689 Cr | ₹1208 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹500 | ₹100 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 05 Jun 2004 | 28 Dec 2015 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare | Nifty Pharma TRI |
| Turn Over | 21% | 26.49% |
| Expense Ratio | 1.81 | 2.14 |
| Manager | Sailesh Raj Bhan | Meeta Shetty |
| ISIN Code | INF204K01968 | INF277K016A9 |
| Exits Load | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 |
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 1 Month | 3.03% | 4.66% |
| 6 Month | 13.37% | 16.53% |
| 1 Year | 36.31% | 41.34% |
| 3 Year | 20.52% | 22.4% |
| 5 Year | 27.7% | 27.33% |
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 6 Month | - | - |
| 1 Year | 26.5% | 31.82% |
| 3 Year | 30.42% | 32.32% |
| 5 Year | 25.06% | 25.8% |
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 1 Year | 17.79% | 6.67% |
| 3 Year | 20.87% | 17.46% |
| 5 Year | 20.18% | 14.22% |
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Standard Deviation | 14.36% | 14.23% |
| Sharp | 0.68% | 0.74% |
| Beta | 0.91% | 0.9% |
| Alpha | 1.57% | 2.85% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Name | Sailesh Raj Bhan | Meeta Shetty |
| Total AUM | ₹96086 Cr | ₹17847 Cr |
| Fund Manage | 5 | 5 |
| Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Others | 4.4 | 5.39 |
| Large Cap | 45.96 | 40.33 |
| Mid Cap | 27.12 | 30.82 |
| Small Cap | 22.52 | 23.46 |
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Others | 4.4 | 5.39 |
| Pharmaceuticals & Biotechnology | 75.86 | 76.28 |
| Healthcare Services | 17.38 | 14.31 |
| Retailing | 2.36 | 0.66 |
| Fertilizers & Agrochemicals | - | 0.83 |
| Chemicals & Petrochemicals | - | 0.39 |
| Insurance | - | 2.14 |
Top Comparisons
HDFC MNC Fund - Regular (G)
3Y Returns0%
UTI - MNC Fund - Regular Plan - Growth Option
3Y Returns13.08%
Mirae Asset Great Consumer Fund - Regular Plan - Growth option
3Y Returns18.81%
Sundaram Consumption Fund(Formerly Known as Sundaram Rural and Consumption Fund Regular Plan - Growth)
3Y Returns19.77%
Aditya Birla Sun Life Multi Asset Allocation Fund-Regular Growth
3Y Returns0%
Quant Multi Asset Fund-Growth
3Y Returns20.08%
ICICI Prudential Banking and PSU Debt Fund - Growth
3Y Returns6.31%
Tata Banking & PSU Debt Fund-Regular Plan-Growth
3Y Returns4.97%